Cetin, ZeynepGunduz, OzgurTopuz, Ruhan D.Dokmeci, DikmenKaradag, Hakan C.Ulugol, Ahmet2024-06-122024-06-1220210302-282X1423-0224https://doi.org/10.1159/000511541https://hdl.handle.net/20.500.14551/22543Objective: Hydrogen sulfide is an endogenous gaseous mediator that has been indicated to have a role in pain mechanisms. In this study, we aimed to detect brain and spinal cord hydrogen sulfide levels during different phases of tolerance and dependence to morphine and to determine the effects of inhibition of endogenous hydrogen sulfide production on the development of tolerance and dependence. Methods: Morphine tolerance and dependence was developed by subcutaneous injection of morphine (10 mg/kg) twice daily for 12 days. Physical dependence was determined by counting the jumps for 20 min, which is a withdrawal symptom occurring after a single dose of naloxone (5 mg/kg) administered intraperitoneally (i.p.). Propargylglycine (30 mg/kg, i.p.), a cystathionine-gamma-lyase inhibitor, and hydroxylamine (12.5 mg/kg, i.p.), a cystathionine-beta-synthase inhibitor, were used as hydrogen sulfide synthase inhibitors. The tail-flick and hot-plate tests were used to determine the loss of antinociceptive effects of morphine and development of tolerance. Results: It was found that chronic and acute uses of both propargylglycine and hydroxylamine prevented the development of tolerance to morphine, whereas they had no effect on morphine dependence. Chronic and acute administrations of hydrogen sulfide synthase inhibitors did not exert any difference in hydrogen sulfide levels in brain and spinal cords of both morphine-tolerant and -dependent animals. Conclusion: It has been concluded that hydrogen sulfide synthase inhibitors may have utility in preventing morphine tolerance.en10.1159/000511541info:eu-repo/semantics/closedAccessMorphineToleranceDependenceHydrogen SulfideNitric-Oxide SynthasePhysical-DependenceNeuropathic PainMechanismsArticle803264270Q3WOS:0005905780000012-s2.0-8509665219533207349Q2